The only prerequisite is that the immunizers are already “well established” abroad, which should open the door for doses from Pfizer-BioNTech, Johnson & Johnson and Moderna
A India announced on Thursday, 27, that it will no longer require that vaccines against Covid-19 be tested locally before joining the national immunization campaign. The only prerequisite is that they are already “well established” abroad, as is the case with Pfizer–BioNTech, Johnson & Johnson e Modern. This flexibility aims to increase the amount of doses available and, consequently, accelerate the rate of inoculations. India is currently experiencing the worst outbreak of new coronavirus in the world, but only completely vaccinated 3% of its 1.3 billion inhabitants – the lowest rate among the ten countries with the most cases of the disease in the world. For the time being, the country has only used immunizers from AstraZeneca–Oxfor Universityd, produced by the Serum Institute, and Covaxin, manufactured by Bharat Biotech. However, production is well below demand from India, which has already started to apply some doses of the Russian Sputnik V. This Thursday, 27, 211,298 new infections by the coronavirus were registered, but experts believe that there is a huge underreporting as the pandemic spreads in the rural areas of the country, where the health system is more precarious.